GLUCOVANCE Side Effects

6943096-5 | Hyperlactacidaemia, Metabolic Acidosis
on Aug 18, 2010 Male patient from GERMANY , 53 years of age, was diagnosed with type 2 diabetes mellitus, hiv test positive (What is hiv test positive?), pulmonary hypertension (What is pulmonary hypertension?), depression (What is depression?) and was treated with Glucovance (View Usage). Patient experienced the following unwanted or unexpected effects: hyperlactacidaemia, metabolic acidosis. Glucovance dosage: (metformin 500mg,glibenclamide 2.5mg). During the same period patient was treated with SUSTIVA (Formulation:sustiva 600mg) (View Sustiva Review and Sustiva Label ), ISENTRESS (Formulation:isentress 400mg) (View Isentress Review and Isentress Label ), TELZIR (View Telzir Review and Telzir Label ), NORVIR (View Norvir Review and Norvir Label ), REVATIO (Revatio 20mg) (View Revatio Review and Revatio Label ), EFFEXOR (View Effexor Review and Effexor Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), MEPRONIZINE (View Mepronizine Review and Mepronizine Label ).

6929041-7 | Syncope
Patient was taking Glucovance (View Usage). Patient had the following side effects: syncope on Aug 04, 2010 from GERMANY Additional patient health information: Female patient , 50 years of age, weighting 165.3 lb, was diagnosed with hyperglycaemia and. Glucovance dosage: Film Coated Tab;1df=2.5/500mg.

6928035-5 | Coma, Hypoglycaemia
Adverse event was reported on Jul 21, 2010 by a Female patient taking Glucovance (View Usage) (Dosage: 1 Df:3 Df) . Location: GERMANY , 16 years of age, After Glucovance was administered, patient had the following side effects: coma, hypoglycaemia.

6922871-7 | Circulatory Collapse
on Aug 04, 2010 Female patient from GERMANY , 50 years of age, weighting 165.3 lb, was diagnosed with hyperglycaemia and was treated with Glucovance (View Usage). Patient experienced the following unwanted or unexpected effects: circulatory collapse. Glucovance dosage: Film Coated Tab;1df=2.5/500mg.


6919689-8 | Renal Disorder
on Jul 23, 2010 Male patient from GERMANY , 73 years of age, was treated with Glucovance (View Usage). Patient had the following side effects: renal disorder. Glucovance dosage: Start Before 1 Year 1df=5/500mg.

6913648-7 | Nausea
Patient was taking Glucovance (View Usage). After Glucovance was administered, patient had the following side effects: nausea (What is nausea?) on Aug 06, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 219.0 lb, was diagnosed with type 2 diabetes mellitus and. Glucovance dosage: 5/500 X 2 Bid Po.

6893718-2 | Coma, Hypoglycaemia
Adverse event was reported on Jul 21, 2010 by a Female patient taking Glucovance (View Usage) (Dosage: 1 Df:3 Df) . Location: GERMANY , 16 years of age, Patient experienced the following unwanted or unexpected effects: coma, hypoglycaemia.

6880281-5 | Nausea
on Apr 28, 2010 Female patient from UNITED STATES , 72 years of age, weighting 200.6 lb, was diagnosed with diabetes mellitus and was treated with Glucovance (View Usage). Patient had the following side effects: nausea (What is nausea?). Glucovance dosage: 1df-2.5mg/500mg.

6880280-3 | Abdominal Pain, Asthenia, Back Pain, Dizziness, Dyspnoea, Nausea
on Dec 24, 2009 Female patient from UNITED STATES , 58 years of age, weighting 189.6 lb, was diagnosed with diabetes mellitus and was treated with Glucovance (View Usage). After Glucovance was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), asthenia, back pain (What is back pain?), dizziness (What is dizziness?), dyspnoea, nausea (What is nausea?). Glucovance dosage: At Times 1/2 Tab At Bedtime (hs). During the same period patient was treated with RAMIPRIL (View Ramipril Review and Ramipril Label ).

6880278-5 | Gastrointestinal Disorder
Patient was taking Glucovance (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal disorder on Oct 08, 2009 from UNITED STATES Additional patient health information: Female patient , 70 years of age, . Glucovance dosage: .

6867438-4 | Extrasystoles, Ventricular Extrasystoles
Adverse event was reported on Jul 12, 2010 by a Male patient taking Glucovance (View Usage) (Dosage: Also 500mg 2 In 1d May2010-jun2010, 1month) was diagnosed with type 2 diabetes mellitus and. Location: GERMANY , 79 years of age, weighting 143.3 lb, Patient had the following side effects: extrasystoles, ventricular extrasystoles. During the same period patient was treated with COVERSUM (View Coversum Review and Coversum Label ), DIAMICRON (View Diamicron Review and Diamicron Label ).

6771357-1 | Abdominal Distension, Nausea
on Jun 09, 2010 Female patient from GERMANY , 49 years of age, was treated with Glucovance (View Usage). After Glucovance was administered, patient had the following side effects: abdominal distension, nausea (What is nausea?). Glucovance dosage: 2 Df = 500mg/2.5mg. During the same period patient was treated with VICTOZA (View Victoza Review and Victoza Label ), CRESTOR (View Crestor Review and Crestor Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), NOVOMIX (View Novomix Review and Novomix Label ). Patient was hospitalized.

6658627-2 | Gastrointestinal Haemorrhage, Myopathy, Shock Haemorrhagic
on Mar 24, 2010 Male patient from GERMANY , 59 years of age, weighting 227.1 lb, was diagnosed with type 2 diabetes mellitus and was treated with Glucovance (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal haemorrhage, myopathy, shock haemorrhagic. Glucovance dosage: Mid Dec,1.5yrs Ago. During the same period patient was treated with ACTOS (Mid Dec) (View Actos Review and Actos Label ), BYETTA (View Byetta Review and Byetta Label ). Patient was hospitalized and became disabled.

6645941-X | Eschar, Fall, Gastrointestinal Haemorrhage, Myopathy, Shock Haemorrhagic, Ulcer
Patient was taking Glucovance (View Usage). Patient had the following side effects: eschar, fall (What is fall?), gastrointestinal haemorrhage, myopathy, shock haemorrhagic, ulcer (What is ulcer?) on Mar 11, 2010 from GERMANY Additional patient health information: Male patient , 59 years of age, was diagnosed with diabetes mellitus and. Glucovance dosage: Mid Dec,1.5yrs Ago. During the same period patient was treated with ACTOS (Mid Dec) (View Actos Review and Actos Label ). Patient was hospitalized.

6564436-5 | Hepatitis, Rash
Adverse event was reported on Jan 20, 2010 by a Male patient taking Glucovance (View Usage) (Dosage: 1 Df= 2.5mg/500mg) was diagnosed with diabetes mellitus and. Location: GERMANY , 62 years of age, After Glucovance was administered, patient had the following side effects: hepatitis (What is hepatitis?), rash (What is rash?).

6522238-X | Convulsion, Hypoglycaemia, Loss Of Consciousness, Nephrolithiasis, Renal Failure Acute, Renal Tubular Necrosis
on Dec 22, 2009 Female patient from GERMANY , 81 years of age, was diagnosed with diabetes mellitus and was treated with Glucovance (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, hypoglycaemia, loss of consciousness, nephrolithiasis, renal failure acute, renal tubular necrosis. Glucovance dosage: . During the same period patient was treated with LIPANTHYL (View Lipanthyl Review and Lipanthyl Label ), COVERSYL (View Coversyl Review and Coversyl Label ), VASTAREL (View Vastarel Review and Vastarel Label ). Patient was hospitalized.

6506569-5 | Convulsion, Hypoglycaemia, Loss Of Consciousness, Nephrolithiasis, Renal Tubular Necrosis
on Dec 11, 2009 Female patient from GERMANY , 81 years of age, was diagnosed with diabetes mellitus and was treated with Glucovance (View Usage). Patient had the following side effects: convulsion, hypoglycaemia, loss of consciousness, nephrolithiasis, renal tubular necrosis. Glucovance dosage: . During the same period patient was treated with LIPANTHYL (View Lipanthyl Review and Lipanthyl Label ), COVERSYL (View Coversyl Review and Coversyl Label ), VASTAREL (View Vastarel Review and Vastarel Label ). Patient was hospitalized.

6382671-6 | Diabetes Mellitus Inadequate Control, Product Substitution Issue
Patient was taking Glucovance (View Usage). After Glucovance was administered, patient had the following side effects: diabetes mellitus inadequate control, product substitution issue on Sep 28, 2009 from UNITED STATES Additional patient health information: Female patient , 63 years of age, was diagnosed with diabetes mellitus and. Glucovance dosage: 1 Tablet Twice Daily Po.

6329644-7 | Pruritus, Rash, Urticaria
Adverse event was reported on Aug 21, 2009 by a Male patient taking Glucovance (View Usage) (Dosage: 500mg Coated Tabs) was diagnosed with diabetes mellitus inadequate control, abdominal exploration, depression (What is depression?) and. Location: GERMANY , 46 years of age, Patient experienced the following unwanted or unexpected effects: pruritus, rash (What is rash?), urticaria. During the same period patient was treated with XENETIX (1 Intake, 350mg,injection) (View Xenetix Review and Xenetix Label ), GLIBENCLAMIDE (5mg,tablet) (View Glibenclamide Review and Glibenclamide Label ), SERESTA (View Seresta Review and Seresta Label ), LEPONEX (View Leponex Review and Leponex Label ), DIVARIUS (View Divarius Review and Divarius Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), LANTUS (View Lantus Review and Lantus Label ), NOVORAPID (View Novorapid Review and Novorapid Label ).

6313043-8 | Anger, Back Pain, Blood Glucose Increased, Constipation, Joint Stiffness, Skin Ulcer
on Jun 26, 2009 Female patient from UNITED STATES , 60 years of age, weighting 143.3 lb, was treated with Glucovance (View Usage). Patient had the following side effects: anger, back pain (What is back pain?), blood glucose increased, constipation (What is constipation?), joint stiffness, skin ulcer. Glucovance dosage: 1 Dosage Form = 2.5mg/500mg; Initially Taken Glucovance 1.25mg/250 Bid.

6313038-4 | Blood Glucose Fluctuation
on Nov 10, 2008 Male patient from UNITED STATES , 52 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Glucovance (View Usage). After Glucovance was administered, patient had the following side effects: blood glucose fluctuation. Glucovance dosage: .

6293548-9 | Lactic Acidosis, Renal Failure Acute
Patient was taking Glucovance (View Usage). Patient experienced the following unwanted or unexpected effects: lactic acidosis, renal failure acute on Jul 23, 2009 from GERMANY Additional patient health information: Female patient , 62 years of age, was diagnosed with diabetes mellitus, acute pulmonary oedema, hypertension and. Glucovance dosage: . During the same period patient was treated with METFORMIN HCL (Metformin Mylan Tablet 1000 Mg) (View Metformin Hcl Review and Metformin Hcl Label ), LASIX (Solution For Injection) (View Lasix Review and Lasix Label ), ODRIK (View Odrik Review and Odrik Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

6267092-9 | Pruritus, Rash
Adverse event was reported on Jul 03, 2009 by a Male patient taking Glucovance (View Usage) (Dosage: 500mg Coated Tabs) was diagnosed with diabetes mellitus inadequate control, abdominal exploration, depression (What is depression?) and. Location: GERMANY , 46 years of age, Patient had the following side effects: pruritus, rash (What is rash?). During the same period patient was treated with XENETIX (1 Intake, 350mg,injection) (View Xenetix Review and Xenetix Label ), GLIBENCLAMIDE (5mg,tablet) (View Glibenclamide Review and Glibenclamide Label ), SERESTA (View Seresta Review and Seresta Label ), LEPONEX (View Leponex Review and Leponex Label ), DIVARIUS (View Divarius Review and Divarius Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), LANTUS (View Lantus Review and Lantus Label ), NOVORAPID (View Novorapid Review and Novorapid Label ).

6252460-1 | Congenital Musculoskeletal Anomaly, Dysplasia, Limb Malformation, Pulmonary Hypoplasia, Rib Hypoplasia, Spine Malformation, Talipes
on Jun 26, 2009 Male patient from UNITED STATES , weighting 6.61 lb, was diagnosed with diabetes mellitus, multiple sclerosis (What is multiple sclerosis?), pain (What is pain?), incontinence, fatigue, blood cholesterol increased and was treated with Glucovance (View Usage). After Glucovance was administered, patient had the following side effects: congenital musculoskeletal anomaly, dysplasia, limb malformation, pulmonary hypoplasia, rib hypoplasia, spine malformation, talipes. Glucovance dosage: . During the same period patient was treated with REBIF (View Rebif Review and Rebif Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), DITROPAN (View Ditropan Review and Ditropan Label ), PROVIGIL (View Provigil Review and Provigil Label ), CRESTOR (View Crestor Review and Crestor Label ).

6241148-9 | Hypoglycaemia, Loss Of Consciousness
on Jun 18, 2009 Male patient from UNITED STATES , 72 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Glucovance (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia, loss of consciousness. Glucovance dosage: 1df=10mg/1000mg[5mg/500mgbid]. During the same period patient was treated with ACTOS (View Actos Review and Actos Label ), JANUVIA (View Januvia Review and Januvia Label ), PRANDIN (View Prandin Review and Prandin Label ). Patient was hospitalized.

6152140-7 | Hyperglycaemia, Pollakiuria, Product Quality Issue
Patient was taking Glucovance (View Usage). Patient had the following side effects: hyperglycaemia, pollakiuria, product quality issue on Apr 09, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 217.0 lb, was diagnosed with type 2 diabetes mellitus and. Glucovance dosage: One Tab Three Times Daily Po.

6081977-8 | Blood Glucose Decreased, Blood Glucose Increased, Dizziness Postural, Dysstasia, Epistaxis, Hyperhidrosis, Tremor, Weight Decreased, Weight Increased
Adverse event was reported on Jul 08, 2008 by a Male patient taking Glucovance (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 69 years of age, weighting 348.3 lb, After Glucovance was administered, patient had the following side effects: blood glucose decreased, blood glucose increased, dizziness postural, dysstasia, epistaxis, hyperhidrosis, tremor, weight decreased, weight increased. During the same period patient was treated with GLUCOPHAGE (View Glucophage Review and Glucophage Label ), TERAZOSIN HCL (View Terazosin Hcl Review and Terazosin Hcl Label ), BYETTA (View Byetta Review and Byetta Label ), AMARYL (View Amaryl Review and Amaryl Label ), LANTUS (View Lantus Review and Lantus Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6054725-5 | Cardiomyopathy
on Jan 20, 2009 Male patient from GERMANY , 60 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Glucovance (View Usage). Patient experienced the following unwanted or unexpected effects: cardiomyopathy (What is cardiomyopathy?). Glucovance dosage: 1 Dosage Form = 5 Mg/500 Mg(metformin Hydrochloride, Glibenclamide).

6031065-1 | Extremity Contracture, Masked Facies
on Dec 31, 2008 Female patient from GERMANY , 28 years of age, was treated with Glucovance (View Usage). Patient had the following side effects: extremity contracture, masked facies. Glucovance dosage: 1 Dosage Form = (glyburide + Metformin Hydrochloride 5 Mg/500 Mg). Patient was hospitalized.

5912549-0 | Hypoglycaemic Coma
Patient was taking Glucovance (View Usage). After Glucovance was administered, patient had the following side effects: hypoglycaemic coma on Oct 03, 2008 from GERMANY Additional patient health information: Female patient , 59 years of age, was diagnosed with type 2 diabetes mellitus and. Glucovance dosage: Started As 4 Dosage Form From 15may To 19jul And Reduced To 2df From 19jul08.. During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ). Patient was hospitalized.

5909831-X | Malaise, Tachycardia
Adverse event was reported on Sep 30, 2008 by a Male patient taking Glucovance (View Usage) (Dosage: Strength 2.5mg/500 Mg For 3-4 Years. Stopped During Hosp. And Re-introduced, And Again Stopped.) was diagnosed with type 2 diabetes mellitus and. Location: GERMANY , 62 years of age, Patient experienced the following unwanted or unexpected effects: malaise, tachycardia. Patient was hospitalized.

5901763-6 | Hypoglycaemia, Syncope
on Sep 22, 2008 Male patient from GERMANY , 75 years of age, was diagnosed with diabetes mellitus, prophylaxis, hypertension and was treated with Glucovance (View Usage). Patient had the following side effects: hypoglycaemia, syncope. Glucovance dosage: . During the same period patient was treated with GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), INSULIN HUMAN (View Insulin Human Review and Insulin Human Label ), TICLOPIDINE HCL (View Ticlopidine Hcl Review and Ticlopidine Hcl Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

5868326-2 | Hypoglycaemia, Intentional Overdose, Lactic Acidosis, Renal Failure Acute
on Aug 26, 2008 Male patient from GERMANY , 47 years of age, was treated with Glucovance (View Usage). After Glucovance was administered, patient had the following side effects: hypoglycaemia, intentional overdose, lactic acidosis, renal failure acute. Glucovance dosage: . During the same period patient was treated with ALCOHOL (View Alcohol Review and Alcohol Label ), ZANIDIP (View Zanidip Review and Zanidip Label ), CRESTOR (View Crestor Review and Crestor Label ). Patient was hospitalized.

5841256-8 | Hepatocellular Injury, Hyperkalaemia, Lactic Acidosis, Renal Failure
Patient was taking Glucovance (View Usage). Patient experienced the following unwanted or unexpected effects: hepatocellular injury, hyperkalaemia, lactic acidosis, renal failure on Aug 07, 2008 from GERMANY Additional patient health information: Male patient , 71 years of age, was diagnosed with diabetes mellitus and. Glucovance dosage: 2 Dosage Form = 2 500mg/5 Mg Coated Tablet. During the same period patient was treated with AVANDAMET (1 Dosage Form = 1 Coated Tablets) (View Avandamet Review and Avandamet Label ), CRESTOR (Crestor Coated Tab) (View Crestor Review and Crestor Label ), PLAVIX (Plavix Coated Tablet) (View Plavix Review and Plavix Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ALDALIX (View Aldalix Review and Aldalix Label ), BROMAZEPAM (View Bromazepam Review and Bromazepam Label ), OXEOL (View Oxeol Review and Oxeol Label ). Patient was hospitalized.

5837043-7 | Weight Increased
Adverse event was reported on Jun 25, 2008 by a Female patient taking Glucovance (View Usage) (Dosage: 1 Dosage Form = 5/500mg) . Location: UNITED STATES , 56 years of age, Patient had the following side effects: weight increased. During the same period patient was treated with LISINOPRIL AND HYDROCHLOROTHIAZIDE (1 Dosage Form = 20/12.5mg) (View Lisinopril And Hydrochlorothiazide Review and Lisinopril And Hydrochlorothiazide Label ).

5837041-3 | Lip Haemorrhage
on Jun 09, 2008 Female patient from UNITED STATES , 64 years of age, was treated with Glucovance (View Usage). After Glucovance was administered, patient had the following side effects: lip haemorrhage. Glucovance dosage: . During the same period patient was treated with AVANDIA (View Avandia Review and Avandia Label ).

5837038-3 | Blood Glucose Increased, Dizziness, Hypoaesthesia, Muscular Weakness
on Apr 28, 2008 Female patient from UNITED STATES , 79 years of age, weighting 138.9 lb, was diagnosed with diabetes mellitus and was treated with Glucovance (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, dizziness (What is dizziness?), hypoaesthesia, muscular weakness. Glucovance dosage: 1 Dosage Form = 5 / 500 Mg.. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), LIPITOR (View Lipitor Review and Lipitor Label ), PRAVACHOL (View Pravachol Review and Pravachol Label ), THYROID SUPPLEMENT (View Thyroid Supplement Review and Thyroid Supplement Label ).

5837036-X | Blood Glucose Increased
Patient was taking Glucovance (View Usage). Patient had the following side effects: blood glucose increased on Mar 05, 2008 from UNITED STATES Additional patient health information: Male patient , 71 years of age, was diagnosed with type 2 diabetes mellitus and. Glucovance dosage: . During the same period patient was treated with JANUVIA (View Januvia Review and Januvia Label ), ACTOS (View Actos Review and Actos Label ).

5837031-0 | Constipation
Adverse event was reported on Mar 27, 2008 by a Female patient taking Glucovance (View Usage) (Dosage: 1 Dosage Form = 2.5 Mg /500 Mg Half Twice Per Day.) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 68 years of age, weighting 138.9 lb, After Glucovance was administered, patient had the following side effects: constipation (What is constipation?).

5837030-9 | Blood Glucose Fluctuation
on Oct 01, 2007 Male patient from UNITED STATES , 74 years of age, was diagnosed with diabetes mellitus and was treated with Glucovance (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose fluctuation. Glucovance dosage: On 24-sep-2007 Glucovance 5/500 Mg Was Increased To Three Tablets Daily.. During the same period patient was treated with VYTORIN (View Vytorin Review and Vytorin Label ), BENICAR (View Benicar Review and Benicar Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ).

5837029-2 | Blood Glucose Decreased, Dizziness
on Sep 14, 2007 Female patient from UNITED STATES , 68 years of age, weighting 130.1 lb, was diagnosed with diabetes mellitus and was treated with Glucovance (View Usage). Patient had the following side effects: blood glucose decreased, dizziness (What is dizziness?). Glucovance dosage: .

5837027-9 | Blood Glucose Decreased, Dizziness, Dry Mouth, Faeces Hard
Patient was taking Glucovance (View Usage). After Glucovance was administered, patient had the following side effects: blood glucose decreased, dizziness (What is dizziness?), dry mouth, faeces hard on Aug 22, 2007 from UNITED STATES Additional patient health information: Female patient , 66 years of age, weighting 138.9 lb, . Glucovance dosage: .

5837025-5 | Blood Glucose Fluctuation
Adverse event was reported on Aug 06, 2007 by a Male patient taking Glucovance (View Usage) (Dosage: 2.5/500 Mg; Dose Increased To 5/500mg On 26-jul-2007) . Location: UNITED STATES , weighting 224.9 lb, Patient experienced the following unwanted or unexpected effects: blood glucose fluctuation. During the same period patient was treated with PRINIVIL (View Prinivil Review and Prinivil Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

5837024-3 | Blood Glucose Increased
on Jul 17, 2007 Male patient from UNITED STATES , 70 years of age, was treated with Glucovance (View Usage). Patient had the following side effects: blood glucose increased. Glucovance dosage: . During the same period patient was treated with TERAZOSIN HCL (View Terazosin Hcl Review and Terazosin Hcl Label ), NORVASC (View Norvasc Review and Norvasc Label ), LASIX (View Lasix Review and Lasix Label ), AVALIDE (View Avalide Review and Avalide Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), ACTOS (View Actos Review and Actos Label ), CRESTOR (View Crestor Review and Crestor Label ), ALLEGRA D (View Allegra-d Review and Allegra-d Label ).

5808753-2 | Blood Glucose Increased
on Jul 10, 2008 Female patient from UNITED STATES , weighting 209.0 lb, was diagnosed with diabetes mellitus and was treated with Glucovance (View Usage). After Glucovance was administered, patient had the following side effects: blood glucose increased. Glucovance dosage: Two Tabs Bid Po.

5807138-2 | Abdominal Pain, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Bleeding Time Prolonged, Blood Alkaline Phosphatase Increased, Diarrhoea, Faeces Discoloured, Gallbladder Operation, Jaundice
Patient was taking Glucovance (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), alanine aminotransferase increased, aspartate aminotransferase increased, bleeding time prolonged, blood alkaline phosphatase increased, diarrhoea, faeces discoloured, gallbladder operation, jaundice (What is jaundice?) on Jul 09, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 210.0 lb, . Glucovance dosage: Daily Po. Patient was hospitalized.

5789898-2 | Blood Triglycerides Increased, Supraventricular Tachycardia
Adverse event was reported on Jun 24, 2008 by a Female patient taking Glucovance (View Usage) (Dosage: 1 Df = 5/500 Units Not Specified, 2 Tabs In Morning And 2 In Evening) . Location: UNITED STATES , 51 years of age, weighting 200.6 lb, Patient had the following side effects: blood triglycerides increased, supraventricular tachycardia. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), HYDROCHLOROTHIAZIDE (1 Df = 20/25 Units Not Specified) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), CYCLOBENZAPRINE HCL (Frequency = 3 Times Daily) (View Cyclobenzaprine Hcl Review and Cyclobenzaprine Hcl Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), HYDROCODONE (View Hydrocodone Review and Hydrocodone Label ), VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ), CALTRATE (View Caltrate Review and Caltrate Label ). Patient was hospitalized.

5778031-9 | Leukopenia, Neutropenia
on Jun 09, 2008 Male patient from GERMANY , 64 years of age, was diagnosed with type 2 diabetes mellitus, pharyngitis and was treated with Glucovance (View Usage). After Glucovance was administered, patient had the following side effects: leukopenia, neutropenia. Glucovance dosage: . During the same period patient was treated with LYRICA (View Lyrica Review and Lyrica Label ), CLAMOXYL (View Clamoxyl Review and Clamoxyl Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), LOVENOX (View Lovenox Review and Lovenox Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), JOSIR (View Josir Review and Josir Label ), RIVOTRIL (1 Dosage Form = 45gtt) (View Rivotril Review and Rivotril Label ). Patient was hospitalized.

5775514-2 | Lactic Acidosis, Overdose, Renal Failure Acute
on Jun 12, 2008 Female patient from GERMANY , 67 years of age, was diagnosed with type 2 diabetes mellitus, cardiac failure and was treated with Glucovance (View Usage). Patient experienced the following unwanted or unexpected effects: lactic acidosis, overdose, renal failure acute. Glucovance dosage: Interrupted On 29-apr-2008 And Reintroduced After 4 Days.. During the same period patient was treated with ODRIK (Formulation:capsule) (View Odrik Review and Odrik Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), LASILIX (View Lasilix Review and Lasilix Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), ZOCOR (View Zocor Review and Zocor Label ), PREVISCAN (View Previscan Review and Previscan Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ). Patient was hospitalized.

5745412-9 | Hypoglycaemia, Malaise
Patient was taking Glucovance (View Usage). Patient had the following side effects: hypoglycaemia, malaise on May 15, 2008 from GERMANY Additional patient health information: Male patient , 63 years of age, . Glucovance dosage: 1 Dosage Form = 1 Tablet. During the same period patient was treated with VASTAREL (View Vastarel Review and Vastarel Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ). Patient was hospitalized.